Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

VA Cooperative Studies Program (CSP)

Menu
Menu
Quick Links
Veterans Crisis Line Badge
My healthevet badge
 

Leveraging Electronic health information to Advance Precision medicine (LEAP)

LEAP experts from several VA medical centers and academic institutions harness “Big” electronic health and other national data sources to provide real-world evidence about pressing health issues. LEAP uses novel methods on VA's electronic health data, the longest-running and largest U.S. electronic health records (EHR) system, to inform population health outcomes, individual precision health, healthcare system management, and quality in clinical practice.

LEAP is a national data initiative and a multi-site collaboration comprised of data scientists, biostatisticians, epidemiologists, informaticians, and clinical leadership partners. VA’s extensive health information archive offers a rich opportunity to develop Precision Medicine–based strategies that can be implemented in pragmatic and attainable ways. LEAP advances national precision medicine initiatives, which leverages large-scale information to customize medical treatments based on a patient’s genetic history, environment, and lifestyle. LEAP utilizes existing large data sources to augment and support the strategic planning, conduct, generalizability, and impact of multi-site randomized clinical trials. Recent work has included a focus on research related to glycemic dysregulation, cardiometabolic conditions, cancers, and COVID-19.

Objectives of LEAP

  • Establishing a quality real-world evidence (RWE) base about health conditions, populations, interventions, and outcomes using VA EHR.
  • Augment and support Randomized Clinical Trials (RCTs) to improve individual and population health.

Ongoing Observational Real-World Evidence Examples

  • Pre-diabetes detection and management
  • Longitudinal progression of glycemic dysregulation
  • Metformin prescribing patterns in pre-diabetes
  • SARS-CoV-2 infection and outcomes in patients with glycemic dysregulation

Key Personnel

  • Jennifer Lee, MD, PhD and Mei-Chiung Shih, PhD (Co-Chairs, VA Palo Alto Health Care System)
  • Natalie Fullenkamp, MA (LEAP National Coordinator, VA Palo Alto Health Care System)
  • Mihaela Aslan, PhD (LEAP Coordinating Center Director (Acting), West Haven CSP Epidemiology Center, VA Connecticut Healthcare System)
  • Julie Lynch, PhD and Kyung Lee, PhD (Co-Investigators, VA Salt Lake City)
  • Patricia Crutchfield (Program Manager, VA Connecticut Healthcare System)

Sponsorship

This is sponsored by VA Cooperative Studies Program (CSP).

Contact

Contact the National Coordinator, Natalie Fullenkamp, for more information.

return to top go